captodiame 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |
| Stem definition | Drug id | CAS RN |
|---|---|---|
| aptamers, classical and mirror ones | 483 | 486-17-9 |
Description:
| Molecule | Description |
|---|---|
|
Synonyms:
|
Captodiamine represents an interesting strategy for achieving benzodiazepine substitution with a low risk of dependence or impairment of cognitive function
|
Drug dosage:
| Dose | Unit | Route |
|---|---|---|
| 0.20 | g | O |
ADMET properties:
None
Approvals:
None
FDA Adverse Event Reporting System (Female)
None
FDA Adverse Event Reporting System (Male)
None
FDA Adverse Event Reporting System (Geriatric)
None
FDA Adverse Event Reporting System (Pediatric)
None
Pharmacologic Action:
| Source | Code | Description |
|---|---|---|
| ATC | N05BB02 | NERVOUS SYSTEM PSYCHOLEPTICS ANXIOLYTICS Diphenylmethane derivatives |
Drug Use | Suggest Off label Use Form| |View source of the data|
| Disease | Relation | SNOMED_ID | DOID |
|---|---|---|---|
| Anxiety disorder | indication | 197480006 | DOID:2030 |
🐶 Veterinary Drug Use
None
🐶 Veterinary products
None
Acid dissociation constants calculated using MoKa v3.0.0
| Dissociation level | Dissociation constant | Type (acidic/basic) |
|---|---|---|
| pKa1 | 8.14 | Basic |
Orange Book patent data (new drug applications)
None
Orange Book exclusivity data (new drug applications)
None
Bioactivity Summary:
None
External reference:
| ID | Source |
|---|---|
| D07316 | KEGG_DRUG |
| 236176 | RXNORM |
| C0301409 | UMLSCUI |
| CHEBI:135521 | CHEBI |
| CHEMBL2110809 | ChEMBL_ID |
| CHEMBL2106143 | ChEMBL_ID |
| DB09014 | DRUGBANK_ID |
| 10240 | PUBCHEM_CID |
| C495502 | MESH_SUPPLEMENTAL_RECORD_UI |
| 625 | INN_ID |
| H93K9455DD | UNII |
| 4025009 | SNOMEDCT_US |
| 005298 | NDDF |
| 005299 | NDDF |
Pharmaceutical products:
None